CClinicalTrials.gg
CompletedNCT05221125Updated Aug 11, 2026

Multimodal Management of Neck and Back Pain in the Emergency Department (Multi-ED)

An interventional study of Psychologically-Informed Physical Therapy (PIPT) in Musculoskeletal Pain, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Duke University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to assess the feasibility and acceptability of psychologically-informed physical therapy (PIPT) in the ED in a pilot study of ED patients with neck or back pain. We will conduct a single-site, prospective trial comparing the combined program in one group with a usual care-only group. Primary outcomes will focus on feasibility based on recruitment and retention rates, and acceptability based on a 5-point patient satisfaction scale, while secondary outcomes will include pain severity, pain interference, anxiety, physical function, opioid use, repeat ED visits, and hospitalizations at 1 hour and at 24 hours, 1 month and 3 months after ED discharge.

We will use pilot study results to develop a protocol for a larger pragmatic randomized clinical trial designed to rigorously evaluate PIPT in the ED combined with Spine Health follow up for ED patients with neck or back pain. We will perform a process evaluation of our proposed clinical trial study design, including characterizing and quantifying the degree of CBT and PT components used by treating PTs while in the ED and during Spine Health follow up, number of Spine Health visits attended in the first month, and integration into usual ED care. Qualitative interviews will be used to identify facilitators, barriers and potential solutions to intervention and research study procedures based on the patients' experience.

02

Conditions studied

  • Musculoskeletal Pain

Browse trials for

03

In context

Musculoskeletal Pain

493 studies on the registry are indexed under Musculoskeletal Pain; 113 are open to participants now.

This study's enrollment of 86 is above the median of 69 across 346 interventional studies indexed under Musculoskeletal Pain.

Browse Musculoskeletal Pain studies →

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults (age 18 years or older),
  • Presented to the ED with pain in the neck and/or back,
  • A diagnosis of musculoskeletal pain as determined by an ED provider,
  • Able to read and understand the consent form in English.

Exclusion criteria

Exclusion Criteria:

  • Suspected to have a non-musculoskeletal cause of pain;
  • Unable to provide informed consent or to comprehend or complete study measures or procedures due to cognitive impairment, including evidence of drug, medication or alcohol intoxication, or due to severe hearing or speech impairment;
  • Unable to safely participate due to critical illness, emergent surgical need, other serious medical condition (including active COVID-19 infection),
  • ED provider judgment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Psychologically-Informed Physical Therapy (PIPT)

    CBT-trained physical therapist evaluation and treatment with recommendation for Spine Health follow up after ED discharge

    Behavioral: Psychologically-Informed Physical Therapy (PIPT)

  • No intervention
    Control

    Usual care only

Interventions

  • BehavioralPsychologically-Informed Physical Therapy (PIPT)

    The PIPT group will receive evaluation and treatment based on the PT's assessment of the individual patient's clinical presentation and condition.

06

What researchers measure

Primary outcomes

  1. Number of ED patients eligible for recruitment as measured by patient log

    Time frame: Post implementation, up to 6 weeks

  2. Number of patients enrolled as measured by patient log

    Time frame: Post implementation, up to 6 weeks

  3. Number of patients retained in study as measured by patient log

    Time frame: Post implementation, up to 6 weeks

  4. Number of patients that found treatment satisfactory via satisfactory questionnaire

    5 point Likert-scale satisfaction scale

    Time frame: Post implementation, up to 6 weeks

Secondary outcomes

  1. Change in Pain Score

    11-point Numeric Rating Scale (NRS) for current pain

    Time frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge

  2. Change in Anxiety Level

    Subjective Units of Discomfort Scales (SUDS)

    Time frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge

  3. Change in Function

    PROMIS-29

    Time frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge

  4. Change in Quality of Life (QoL)

    PROMIS-29

    Time frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge

  5. Change in pain related distress

    Optimal Screening for Prediction of Referral and Outcome (OSPRO) tool

    Time frame: ED pre-treatment (baseline); 1 and 3 months post discharge

  6. Change in self efficacy

    Optimal Screening for Prediction of Referral and Outcome (OSPRO) tool

    Time frame: ED pre-treatment (baseline); 1 and 3 months post discharge

  7. Change in severity of chronic pain

    Simplified graded chronic pain scale

    Time frame: ED pre-treatment (baseline); 1 and 3 months post discharge

  8. Number of pain medications prescribed

    as measured by chart review

    Time frame: up to 3 months post discharge

  9. Number of Spine Health referrals for follow up PT

    as measured by chart review

    Time frame: At ED discharge (up to 48 hours)

  10. Number of Spine Health visits for follow up PT

    as measured by chart review

    Time frame: up to 3 months post discharge

  11. Number of repeat ED visits

    as measured by chart review

    Time frame: up to 3 months post discharge

  12. Number of patient hospitalizations

    as measured by chart review

    Time frame: up to 3 months post discharge

07

Study locations

1 site
  • Duke University Hospital Emergency Department
    Durham, North Carolina 27710, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05221125
Lead sponsor
Duke University
Collaborators
Duke Clinical Research Institute
Responsible party
Sponsor
First posted
Feb 2, 2022
Start date
Jun 6, 2022
Primary completion
Apr 20, 2023
Completion
Jul 31, 2023
Last update
Aug 11, 2026

Study contacts

Corey Simon, PhD
principal investigator · Duke University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion